A Study of Pertuzumab in Participants With Prostate Cancer

Clinical trial NCT02480010 · TERMINATED

Trial details

NCT number: NCT02480010
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2003-09-01
Primary completion: 2005-09-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.